Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AN-152 (AEZS-108) in Castration- and Taxane-Resistant Prostate Cancer
NCT01240629Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Nov 2010
- Primary completion
- Feb 2017
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of zoptarelin doxorubicin in prostate cancer (PCa), sponsored by University of Southern California. Started Nov 2010; status: completed.
02
Drugs
zoptarelin doxorubicin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01240629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01240629.